Anticoagulant Rodenticide Toxicosis in Dogs: Clinical Management

Bottom line

Anticoagulant rodenticides inhibit vitamin K epoxide reductase, depleting the active vitamin K-dependent factors II, VII, IX, and X; because factor VII has the shortest half-life (~6 h), PT prolongs first, typically 48-72 h post-ingestion. Clinical bleeding is delayed 2-5 days, so a normal exam early does not exclude significant exposure. The antidote is vitamin K1 (phytonadione) given orally with a fatty meal, dosed and continued for weeks by generation, but K1 takes hours to restore factor synthesis, so an actively bleeding dog needs fresh frozen plasma or whole blood for immediate clotting factors. The single most-missed step is rechecking PT 48-72 h AFTER stopping vitamin K1 to confirm the coagulopathy has truly resolved.

Clinical facts

• Mechanism: inhibition of vitamin K epoxide reductase, blocking recycling of vitamin K1 and depleting active factors II, VII, IX, X. [1]
• First marker: PT (driven by factor VII, half-life ~6 h) prolongs first, usually 48-72 h post-ingestion, and is disproportionately prolonged relative to aPTT. [2]
• Onset of signs: delayed 2-5 days; bleeding may appear before the owner suspects exposure. [1][2]
• Antidote: vitamin K1 (phytonadione) PO with a fatty meal - NOT vitamin K3/menadione. [1][3][5]
• Active bleeding: fresh frozen plasma or whole blood for immediate factors; K1 alone takes hours. [3]
• Critical rule: recheck PT 48-72 h after the LAST vitamin K1 dose. [1][2][3]

Mechanism and pharmacology

Anticoagulant rodenticides inhibit the enzyme vitamin K epoxide reductase, which normally regenerates reduced vitamin K1 needed as a cofactor for gamma-carboxylation of the vitamin K-dependent clotting factors II, VII, IX, and X. [1] With the recycle blocked, existing carboxylated factor stores are consumed and not replaced, producing a functional deficiency of all four factors. Non-functional decarboxylated precursors (PIVKA - proteins induced by vitamin K absence or antagonism) accumulate and can be measured as a sensitive marker of vitamin K antagonism. [2]

The factors deplete in order of their half-lives - factor VII is shortest (~6 h), followed by IX and X, with prothrombin (II) the longest-lived. [2] This is why the extrinsic-pathway test (PT) becomes abnormal before the intrinsic/common tests.

Generations matter for duration of therapy. First-generation compounds (warfarin, pindone, chlorophacinone, diphacinone) generally required multiple feedings in the target species and clear relatively quickly. Second-generation "superwarfarins" (brodifacoum, bromadiolone, difethialone, difenacoum) are far more potent - lethal after a single feeding - and persist much longer. [1] In poisoned dogs, plasma brodifacoum half-lives on the order of days (median ~2.4 days) have been reported, underlying the need for extended antidotal therapy rather than a brief course. [4]

Clinical signs and timeline

Because functional factors are only depleted after existing stores are exhausted, clinical bleeding is characteristically DELAYED. Coagulation times begin to prolong ~2-5 days after ingestion, with overt clinical bleeding typically appearing ~3-7 days post-ingestion. [1][2] A dog presented within hours of ingestion is expected to look entirely normal - absence of signs early is not reassurance.

When bleeding does occur it is often into body cavities and serosal surfaces rather than external. Reported presentations include lethargy, weakness, inappetence, and dyspnea/respiratory distress from hemothorax or pulmonary hemorrhage; hemoabdomen; hematomas and petechiation; epistaxis; hematemesis, melena, or hematochezia; hematuria; and lameness or joint swelling from hemarthrosis. [1] Tachycardia, pallor, and hypovolemia reflect the volume of blood loss.

Diagnosis and coagulation monitoring

PT is the earliest and most sensitive screening test. Driven by factor VII, PT prolongs first, usually 48-72 h post-ingestion, and is disproportionately prolonged compared with aPTT in anticoagulant toxicosis. [2] aPTT and thrombin-based tests prolong shortly after as more factors deplete; by the time a dog is overtly bleeding, both PT and PTT are typically elevated. [1]

Where exposure is uncertain and vitamin K1 is being withheld, obtain a baseline PT and recheck at 48 h (and 72 h); if PT remains normal through 72 h, significant exposure is excluded and treatment is not required. [1][3] Supportive findings include regenerative or acute (pre-regenerative) anemia and hypoproteinemia from blood loss. PIVKA assays and quantitative anticoagulant panels can confirm vitamin K antagonism and identify the specific active ingredient; whenever possible, identify the product and its active compound, since generation dictates treatment duration. [2]

Decontamination

Decontamination is worthwhile only in the recent, asymptomatic ingestion - never induce emesis in a coagulopathic or compromised patient. For bait pellets, emesis is likely effective for up to ~4 hours; denser bar/block forms may linger, extending the useful window to as long as ~8 hours. Beyond ~8 hours, emesis and charcoal are unlikely to help. [3] Follow with activated charcoal (with a cathartic) to limit ongoing absorption; enterohepatic recirculation of some compounds is the rationale for charcoal after successful emesis. [1] Merck cites activated charcoal at 1-2 g/kg PO. [1]

Vitamin K1 antidotal therapy and dosing

The antidote is vitamin K1 (phytonadione). Vitamin K3 (menadione) is NOT effective for anticoagulant rodenticide toxicity and should not be substituted. [5]

• Merck Veterinary Manual: 2.5 mg/kg PO q12h for 28 days, OR 5 mg/kg PO q24h for 28 days, with oral dosing given with a fatty meal to enhance bioavailability. [1]
• A commonly cited clinical regimen: vitamin K1 3-5 mg/kg/day PO divided q12h, given with a fatty meal. [3]

Give vitamin K1 ORALLY with food. Avoid the IV route (risk of anaphylaxis), and IM/SC injection also carries reaction and hematoma risk in a coagulopathic patient. [3][5]

Duration is set by generation/product:

• First-generation / short-acting (warfarin, pindone): ~2 weeks (14 days). [1][3]
• Bromadiolone: ~21 days. [3]
• Second-generation (brodifacoum, difethialone, and long-acting indandiones): ~4 weeks (28 days), occasionally longer. [1][2][3]

When the product is unknown, treat as a long-acting second-generation exposure.

Managing active hemorrhage

Vitamin K1 restores endogenous factor synthesis but is not immediate - newly carboxylated factors take on the order of 6-12 h to appear - so it does NOT stop active bleeding on its own. [3] A dog that is actively hemorrhaging or hypovolemic needs a transfusion of clotting factors NOW: fresh frozen plasma or whole blood, chosen by availability and whether the patient also needs red cells. [1][3]

Practical measures: fresh frozen plasma dosed ~10 mL/kg over 1-4 hours, repeated as needed; fresh whole blood (typed/cross-matched) when oxygen-carrying capacity is also compromised. [3] Provide supplemental oxygen, minimize handling, and restrict activity until the patient is non-coagulopathic. For hemothorax, replace clotting factors FIRST; perform thoracocentesis only if effusion is impairing oxygenation and ventilation, since tapping a coagulopathic chest can worsen bleeding. [3]

Monitoring and prognosis

The non-negotiable monitoring step is a PT recheck 48-72 h AFTER the last dose of vitamin K1 - not while still on it. [2][3] Because K1 normalizes PT within hours, a PT drawn during therapy looks fine even if body stores of the anticoagulant persist; only a recheck after the drug is cleared confirms the dog can carboxylate factors on its own. [1] If that post-cessation PT is prolonged, resume vitamin K1 for an additional 1-2 weeks and repeat the off-therapy PT until it normalizes. [1]

Prognosis is generally good with prompt recognition and appropriate therapy. [2] Outcome tracks the severity and location of bleeding - hemorrhage into the CNS, pericardium, or airway is more dangerous than contained bleeding (e.g., into a joint), and delayed presentation with massive cavity hemorrhage carries the highest risk. [3]

Frequently Asked Questions

What is the vitamin K1 dose for anticoagulant rodenticide toxicity in dogs?

The Merck Veterinary Manual gives phytonadione (vitamin K1) 2.5 mg/kg PO q12h for 28 days, or 5 mg/kg PO q24h for 28 days, administered with a fatty meal to enhance bioavailability. [1] A widely cited clinical regimen is 3-5 mg/kg/day PO divided q12h, also with a fatty meal. [3] Give it orally with food; avoid IV administration (anaphylaxis risk). Use vitamin K1, not vitamin K3/menadione, which is ineffective for this indication. [5]

When does PT prolong after anticoagulant rodenticide ingestion?

PT typically prolongs 48-72 hours after ingestion. [2] It is the earliest and most sensitive marker because factor VII, which drives the PT, has the shortest half-life (~6 hours) of the vitamin K-dependent factors, so it depletes first. [2] In uncertain exposures where K1 is withheld, obtain a baseline PT and recheck at 48 h; if PT is prolonged, start treatment. [1][3]

How long do you treat second-generation anticoagulant toxicosis?

Second-generation compounds (brodifacoum, bromadiolone, difethialone) are more potent and persist far longer than first-generation agents, so they require about 4 weeks (28 days) of vitamin K1, occasionally longer. [1][2][3] First-generation/short-acting agents like warfarin generally need only ~2 weeks. [1][3] When the product is unknown, treat as a long-acting second-generation exposure.

When do you recheck PT after stopping vitamin K1?

Recheck PT 48-72 hours AFTER the last vitamin K1 dose - not during therapy. [2][3] Vitamin K1 normalizes PT within hours, so a PT drawn while the dog is still on the antidote can look normal even though the anticoagulant is still present in tissues. Only an off-therapy PT confirms the dog can maintain normal coagulation independently. If it is prolonged, resume vitamin K1 for another 1-2 weeks and repeat. [1]

Does vitamin K1 stop active bleeding immediately?

No. Vitamin K1 restores the dog's own synthesis of clotting factors, but newly carboxylated factors take roughly 6-12 hours to appear, so K1 alone does not control acute hemorrhage. [3] An actively bleeding or hypovolemic dog needs immediate clotting factors from fresh frozen plasma (~10 mL/kg over 1-4 h) or fresh whole blood, alongside vitamin K1 and supportive care. [1][3]

A dog ingested rodenticide but is asymptomatic - do I give vitamin K1 or just monitor PT?

Two accepted approaches. After decontamination you can either (1) start prophylactic vitamin K1 immediately, or (2) withhold K1 and monitor PT - obtain a baseline, recheck at 48 and 72 hours, and treat only if PT rises; if PT stays normal through 72 hours, no treatment is needed. [3] The monitoring approach avoids treating dogs that were never significantly exposed but requires reliable follow-up; when the product is a long-acting second-generation agent or the compound is unknown, many clinicians favor prophylactic K1. [1][3]

Why are clinical signs of rodenticide poisoning delayed?

Existing carboxylated clotting factors keep coagulation normal until they are consumed. Anticoagulants block regeneration of active factors, so it takes 1-2 days to exhaust stores; coagulation times begin to prolong ~2-5 days after ingestion, with overt clinical bleeding typically appearing ~3-7 days post-ingestion. [1][2] This is why a normal early presentation does not exclude a serious exposure and why PT monitoring or prophylactic K1 is warranted.

Is vitamin K3 (menadione) an acceptable substitute for vitamin K1?

No. Vitamin K3 (menadione) is not effective for treating anticoagulant rodenticide toxicity, in part because of its delayed onset of action; the appropriate antidote is vitamin K1 (phytonadione). [5] Dose K1 orally with a fatty meal for the duration dictated by the rodenticide generation. [1]